US PLUSView™ to be implemented on hand-held mobile phone-based ultrasound devices, addressing growing market for patient care
STOCKHOLM – July 7, 2016 – ContextVision, the leading provider of medical image processing software, has signed a contract to bring their its world leading ultrasound image enhancement software US PLUSView™ to hand-held iOS-based mobile devices. The move will make advanced image processing software available on small hand-held devices, making ultrasound examinations reachable and affordable to more users outside traditional clinics.
‘Compact ultrasound devices offer a number of significant advantages to point-of-care providers, including ease of operation, lower costs and reduced energy consumption, making this a rapidly growing market segment that ContextVision can easily address,’ said Fredrik Palm, Vice President – OEM Business, ContextVision. ‘ContextVision is taking major steps toward high quality images on smaller devices, and mobile device platforms like iOS and Android are increasingly becoming the platforms of choice to extend high quality care beyond the hospital. It’s a great match for us.’
As ultrasound devices shrink and make ultrasound technologies available for more users outside of radiology, image quality becomes increasingly critical. With image enhancement provided by ContextVision, system manufacturers can provide users the best image available, enabling them to perform more accurate and faster diagnosis.
US PLUSView offers a number of important features that make it ideal for hand-carried use, including:
• Superior edge enhancement
• Excellent soft tissue differentiation
• Enhanced margin continuity
• Efficient line connectivity
• Clear lines and edge conspicuity
• Great grayscale contrast
ContextVision is a medical technology company specializing in image analysis and image processing. Its cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. As an industry pioneer for more than 30 years, ContextVision has decided to take a lead position within deep learning, the latest technology within artificial intelligence. ContextVision is currently investing heavily in this field to develop a broader product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography and is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.